<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02313116</url>
  </required_header>
  <id_info>
    <org_study_id>DxP 2012-02 (Part B)</org_study_id>
    <nct_id>NCT02313116</nct_id>
  </id_info>
  <brief_title>Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)</brief_title>
  <official_title>Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diagnostic Photonics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diagnostic Photonics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This intraoperative study is a prospective study analyzing specimens from fifty subjects.&#xD;
      Patients scheduled to undergo breast-conserving surgery will be recruited in accordance with&#xD;
      the inclusion and exclusion criteria. The study period per subject is the time it takes to&#xD;
      assess the ex vivo breast tissue sample using the study device. Image review will be&#xD;
      conducted during surgery and compared to the margin status findings in the post-operative&#xD;
      pathology report.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">March 18, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patients With All Positive/Close Margins Correctly Identified With the Device</measure>
    <time_frame>1 week after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Margins With False Positive Device Readings</measure>
    <time_frame>1 week after surgery</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interferometric Synthetic Aperture Microscopy</intervention_name>
    <description>Optical coherence tomography with interferometric synthetic aperture microscopy will be used to image ex vivo breast tissue specimens.</description>
    <other_name>Optical Coherence Tomography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with breast cancer undergoing lumpectomy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women 18 years of age or older&#xD;
&#xD;
          2. Signed informed consent form&#xD;
&#xD;
          3. Women who have been histologically diagnosed with carcinoma of the breast prior to&#xD;
             surgery&#xD;
&#xD;
          4. Patients planning breast preservation and undergoing lumpectomy (partial mastectomy)&#xD;
             procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multicentric disease (histologically diagnosed cancer in two different quadrants of&#xD;
             the breast)&#xD;
&#xD;
          2. Neoadjuvant systemic therapy&#xD;
&#xD;
          3. All T4 tumors&#xD;
&#xD;
          4. Previous radiation in the operated breast&#xD;
&#xD;
          5. Prior surgical procedure in the same quadrant&#xD;
&#xD;
          6. Implants in the operated breast&#xD;
&#xD;
          7. Pregnancy&#xD;
&#xD;
          8. Lactation&#xD;
&#xD;
          9. Participating in any other investigational study for either drug or device which can&#xD;
             influence collection of valid data under this study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Jacobs</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>July 16, 2019</last_update_submitted>
  <last_update_submitted_qc>July 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lumpectomy</keyword>
  <keyword>Breast cancer</keyword>
  <keyword>Optical coherence tomography</keyword>
  <keyword>Tumor margin</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

